All Stories

  1. Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
  2. Family B G Protein-coupled Receptors and their Ligands: From Structure to Function
  3. Copolymerization of Norbornene and Norbornadiene Using a cis-Selective Bimetallic W-Based Catalytic System
  4. Functional Components of Carob Fruit: Linking the Chemical and Biological Space
  5. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors
  6. Calixarenes in Lipase Biocatalysis and Cancer Therapy
  7. Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor
  8. Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs
  9. Rational Drug Design and Synthesis of Molecules Targeting the Angiotensin II Type 1 and Type 2 Receptors
  10. Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors
  11. 32nd Cyprus-Noordwijkerhout-Camerino Symposium: Trends in Drug Research 2014
  12. Synthesis of New Optically Active 2-Pyrrolidinones
  13. Design and Discovery of Novel Antihypertensive Drugs Through Conformation and Bioactivity Studies
  14. Editorial [Hot Topic:Methodologies and Applied Strategies in the Rational Drug Design (Guest Editor: T. Mavromoustakos)]
  15. Partial interdigitation of lipid bilayers
  16. PLS Analysis for Antibacterial Activity of Natural Coumarins Using VolSurf Descriptors
  17. ChemInform Abstract: 3D QSAR/CoMFA and CoMSIA Studies on Antileukemic Steroidal Esters Coupled with Conformationally Flexible Nitrogen Mustards.
  18. The Use of Differential Scanning Calorimetry to Study Drug-Membrane Interactions
  19. Structure elucidation and conformational study of V8
  20. Effects of steroidal carriers of alkylating agents on the phase transition in DPPC membrane bilayers
  21. Preface [Hot topic: Modern Aspects in the Design And Discovery of Novel Antihypertensive Drugs (Guest Editor: Thomas Mavromoustakos)]
  22. Block copolymers with crystalline/amorphous, crystalline/polyelectrolyte and amorphous/polyelectrolyte blocks
  23. Biological activity of myricetin and its derivatives against human leukemic cell lines in vitro
  24. Topography of alphaxalone and Δ16-alphaxalone in membrane bilayers containing cholesterol
  25. Small angle X-ray diffraction studies of (−)-Δ8-tetrahydrocannabinol and its O-methyl analog in membranes
  26. The conformation of (-) 8 α and (-) 8 β-hydroxy-δ9-tetrahydrocannabinols and their interactions with model membranes
  27. Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials
  28. The Use of Differential Scanning Calorimetry to Study Drug-Membrane Interactions
  29. Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials
  30. Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials